ArticleFrontiers in oncology2022

Hepatic arterial infusion chemotherapy combined with PD-1 inhibitors and tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: A tertiary medical center experience.

Laihui Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.